Urology

...then bring the doctors to the men. An on-site screening program at Lockheed addressed that reluctance.

Some tips on deciding which plan or network will consistently produce better outcomes in specialized care.

Addendum questionnaire to June Focus On: Tadalafil

Tadalafil (Cialis) was recently deemed approvable for the treatment of erectile dysfunction (ED). When approved, it will join the widely used PDE5 inhibitor sildenafil citrate as an oral therapy for ED management. Among tadalafil?s characteristics are its rapid onset of action, a duration of action of up to 24 hours, and lack of food influence on the drug?s pharmacokinetics. In this Focus article, the pharmacologic, pharmacokinetic, and therapeutic aspects of tadalafil are reviewed and compared, when possible, with sildenafil and another investigational agent, vardenafil.

Healthcare still has high hopes for the elusive technology

A roundtable discussion with Vincent T. Andriole, MD, Chairperson; Paul B. Iannini, MD; Lionel A. Mandell, MD, FRCPC; Charles H. Nightingale, PhD; Lance R. Peterson, MD

Product Profile

New tools that include IS, Internet processing, ASPs and outsourcing help manage transactions and free resources to focus on core competencies

New formulation: Monthly SC injection form of GnRH agonist for advanced prostate cancer

NME: 5-alpha reductase inhibitor for treatmentof benign prostatic hyperplasia

Fluoroquinolones and nitrofurantoin have surpassed trimethoprim-sulfamethoxazole (TMP-SMZ) as the most frequently prescribed antibiotics for uncomplicated urinary tract infections (UTIs) in women, according to a new national analysis. This is despite well-established recommendations (from the Infectious Disease Society of America and others) that TMP-SMZ is the drug of choice for UTIs due to cost and concerns about antibiotic resistance.

MCOs implement multi-tier benefit to slow drug-spending growth, but future fiscal controls could limit access

Worksite education about overactive bladder needn't be elaborate or expensive to be of great value for employees who endure the condition, care for an affected family member or stigmatize symptoms.

People with overactive bladder, incontinent or not, often think they must tolerate symptoms, but that&s a terrible mistake. Therapy is safe, effective, and uncomplicated.

People with overactive bladder, incontinent or not, often think they must tolerate symptoms, but that&s a terrible mistake. Therapy is safe, effective, and uncomplicated.

Government and private organizations offer a wealth of helpful information. Surf the net, send a letter or make a call.

Current estimates indicate that overactive bladder is a widespread disorder. Yet, these figures only capture people willing to admit to symptoms.

Think overactive bladder is just a nuisance? Many studies prove that it severely diminishes quality of life, including the ability to work productively. The cost is in the billions.

How diabetes works and who it targets.

Ranked by total of all payers, 2000

HIPAA compliance will help, but frequent use of disclaimers also can short-circuit some serious legal ramifications

The challenge for plans will be to merge the individual needs of patients with 'cookbook' population control

Minneapolis Veterans Administration Medical Center-Decreasing or eliminating the use of alprostadil-based erectile dysfunction treatments and converting to 100% sildenafil use would save this VA medical center more than $101,000 annually. Furthermore, the projected savings would allow an additional 405 men with erectile dysfunction to be treated for an entire year, say clinicians at this facility.

News brief.

Prescription drug costs are a favorite target for employers these days, but the forces that drive spending increases range far beyond pricing.

News brief.

News brief.

Alabama Power Company allows employees to shape and guide worksite health promotion program, now in its second decade.

News brief.

Spelling out precisely which elective procedures your health plan will?and will not?cover depends on a clear definition of terms.